| Organoid profiling identifies common responders to chemotherapy in pancreatic cancer H Tiriac, P Belleau, DD Engle, D Plenker, A Deschênes, TDD Somerville, ... Cancer discovery 8 (9), 1112-1129, 2018 | 728 | 2018 |
| Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma ED Thompson, M Zahurak, A Murphy, T Cornish, N Cuka, E Abdelfatah, ... Gut 66 (5), 794-801, 2017 | 418 | 2017 |
| PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas A Cimino-Mathews, E Thompson, JM Taube, X Ye, Y Lu, A Meeker, H Xu, ... Human pathology 47 (1), 52-63, 2016 | 334 | 2016 |
| Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC) TR Cottrell, ED Thompson, PM Forde, JE Stein, AS Duffield, ... Annals of Oncology 29 (8), 1853-1860, 2018 | 329 | 2018 |
| Tumor masses support naive T cell infiltration, activation, and differentiation into effectors ED Thompson, HL Enriquez, YX Fu, VH Engelhard Journal of Experimental Medicine 207 (8), 1791-1804, 2010 | 263 | 2010 |
| Safety and clinical activity of the programmed death-ligand 1 inhibitor durvalumab in combination with poly (ADP-ribose) polymerase inhibitor olaparib or vascular endothelial … JM Lee, A Cimino-Mathews, CJ Peer, A Zimmer, S Lipkowitz, ... Journal of Clinical Oncology 35 (19), 2193, 2017 | 235 | 2017 |
| Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity JD Peske, ED Thompson, L Gemta, RA Baylis, YX Fu, VH Engelhard Nature communications 6 (1), 7114, 2015 | 147 | 2015 |
| The immune microenvironment of breast ductal carcinoma in situ E Thompson, JM Taube, H Elwood, R Sharma, A Meeker, HN Warzecha, ... Modern Pathology 29 (3), 249-258, 2016 | 145 | 2016 |
| A multimodality test to guide the management of patients with a pancreatic cyst S Springer, DL Masica, M Dal Molin, C Douville, CJ Thoburn, B Afsari, L Li, ... Science translational medicine 11 (501), eaav4772, 2019 | 124 | 2019 |
| Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discov. 2018; 8: 1112–1129. doi: 10.1158/2159-8290 H Tiriac, P Belleau, DD Engle, D Plenker, A Deschênes, TDD Somerville, ... CD-18-0349.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 106 | |
| Pan-tumor pathologic scoring of response to PD-(L) 1 blockade JE Stein, EJ Lipson, TR Cottrell, PM Forde, RA Anders, ... Clinical Cancer Research 26 (3), 545-551, 2020 | 93 | 2020 |
| Why is pancreatic cancer so deadly? The pathologist's view RH Hruban, MM Gaida, E Thompson, SM Hong, M Noë, LAA Brosens, ... The Journal of pathology 248 (2), 131-141, 2019 | 88 | 2019 |
| Genomic characterization of malignant progression in neoplastic pancreatic cysts M Noë, N Niknafs, CG Fischer, WM Hackeng, V Beleva Guthrie, ... Nature communications 11 (1), 4085, 2020 | 81 | 2020 |
| Intraductal papillary mucinous neoplasms arise from multiple independent clones, each with distinct mutations CG Fischer, VB Guthrie, AM Braxton, L Zheng, P Wang, Q Song, JF Griffin, ... Gastroenterology 157 (4), 1123-1137. e22, 2019 | 81 | 2019 |
| A phase II study of allogeneic GM-CSF–transfected pancreatic tumor vaccine (GVAX) with Ipilimumab as maintenance treatment for metastatic pancreatic cancer AA Wu, KM Bever, WJ Ho, EJ Fertig, N Niu, L Zheng, RM Parkinson, ... Clinical Cancer Research 26 (19), 5129-5139, 2020 | 79 | 2020 |
| Large cell neuroendocrine carcinoma of the head and neck: a clinicopathologic series of 10 cases with an emphasis on HPV status ED Thompson, EB Stelow, SE Mills, WH Westra, JA Bishop The American journal of surgical pathology 40 (4), 471, 2016 | 78 | 2016 |
| Pattern of invasion in human pancreatic cancer organoids is associated with loss of SMAD4 and clinical outcome W Huang, B Navarro-Serer, YJ Jeong, P Chianchiano, L Xia, C Luchini, ... Cancer research 80 (13), 2804-2817, 2020 | 55 | 2020 |
| Single‐cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions Y Kuboki, CG Fischer, V Beleva Guthrie, W Huang, J Yu, P Chianchiano, ... The Journal of pathology 247 (3), 347-356, 2019 | 55 | 2019 |
| The immunosuppressive niche of soft-tissue sarcomas is sustained by tumor-associated macrophages and characterized by intratumoral tertiary lymphoid structures L Chen, T Oke, N Siegel, G Cojocaru, AJ Tam, RL Blosser, J Swailes, ... Clinical Cancer Research 26 (15), 4018-4030, 2020 | 53 | 2020 |
| Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer LS Ojalvo, ED Thompson, TL Wang, AK Meeker, IM Shih, AN Fader, ... Human pathology 74, 135-147, 2018 | 51 | 2018 |
